It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Sc ...

Globus Medical, Inc. (GMED) reported third-quarter 2024 adjusted earnings per share (EPS) of 83 cents, which beat the Zacks Consensus Estimate by 27.7%. The figure increased 45.6% year over year.The adjusted EPS excludes certain non-recurring expenses and benefits, such as the amortization of intangibles, merger and acquisition-related costs/licensing, and provision for litigation.Without adjustments, the company registered a GAAP diluted EPS of 38 cents, up 3700% from the year-ago figure of 1 cent. Find th ...

Globus Medical, Inc. (NYSE:GMED) Q3 2024 Earnings Conference Call November 5, 2024 6:00 PM ET Company Participants Brian Kearns - SVP, Business Development and IR Daniel Scavilla - President and CEO Keith Pfeil - COO and CFO Conference Call Participants Matthew Miksic - Barclays Dino Weinstock - Wells Fargo Young Li - Jefferies Shagun Singh - RBC Capital Markets Phil Dantoin - Piper Sandler David Saxon - Needham & Company Steven Lichtman - Oppenheimer Matthew Blackman - Stifel Ryan Zimmerman - BTIG Craig Bi ...

For the quarter ended September 2024, Globus Medical (GMED) reported revenue of $625.71 million, up 63.1% over the same period last year. EPS came in at $0.83, compared to $0.57 in the year-ago quarter.The reported revenue represents a surprise of +3.44% over the Zacks Consensus Estimate of $604.93 million. With the consensus EPS estimate being $0.65, the EPS surprise was +27.69%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to dete ...

Globus Medical (GMED) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.57 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 27.69%. A quarter ago, it was expected that this medical device company would post earnings of $0.68 per share when it actually produced earnings of $0.75, delivering a surprise of 10.29%.Over the last four quarters ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC. (Exact name of registrant as specified in its charter) DELAWARE 04-3744954 (State or ...

Exhibit 99.1 Globus Medical Reports Third Quarter 2024 Results AUDUBON, PA, November 5, 2024: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2024. · Worldwide net sales were $625.7 million, an increase of 63.1% · GAAP net income for the quarter was $51.8 million · GAAP diluted earnings per share ("EPS") was $0.38 and non-GAAP diluted EPS was $0.83 · Non-GAAP adjusted EBITDA was $193.7 million, or 31.0% ...

AUDUBON, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2024. Worldwide net sales were $625.7 million, an increase of 63.1%GAAP net income for the quarter was $51.8 millionGAAP diluted earnings per share (“EPS”) was $0.38 and non-GAAP diluted EPS was $0.83Non-GAAP adjusted EBITDA was $193.7 million, or 31.0% of net sales “Our third quarter results reflect the endu ...

The upcoming report from Globus Medical (GMED) is expected to reveal quarterly earnings of $0.65 per share, indicating an increase of 14% compared to the year-ago period. Analysts forecast revenues of $604.93 million, representing an increase of 57.7% year over year.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company's earnings announcement ...

Globus Medical, Inc.’s (GMED) merger with NuVasive is expected to generate significant synergies, enhance its globalization initiatives, expand customer access and bolster ties with surgeons. The company is making a string of product introductions, which is highly promising for the coming quarters. Its robust prospect in the musculoskeletal space also bodes well for continued growth. However, the impacts of macroeconomic challenges and pricing pressure raise concerns about the company’s operational results. ...